Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Study, to Evaluate the Efficacy and Safety of PRO-232 Ophthalmic Solution on the Ocular Surface of Patients Postoperative to Cataract Surgery by Phacoemulsification.

NCT07305987 is registered in ClinicalTrials.gov with Laboratorios Sophia S.A de C.V. as lead sponsor.

NCT NCT07305987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07305987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Study, to Evaluate the Efficacy and Safety of PRO-232 Ophthalmic Solution on the Ocular Surface of Patients Postoperative to Cataract Surgery by Phacoemulsification.
Lead sponsor
Laboratorios Sophia S.A de C.V.
Phase
Phase 3
Overall status
Recruiting
Start date
October 27, 2025
Completion date
July 30, 2026
Enrollment
134 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cataract extraction